Alkermes plc. Contracts & Agreements

Fifth Amendment to License and Collaboration Agreement between Alkermes Pharma Ireland Limited and Biogen International GmbH (as successor to Biogen Swiss Manufacturing GmbH),... (Filed With SEC on July 24, 2024)

Form of Non-Employee Director Non-Qualified Stock Option Award Certificate (rev. 2024) under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 24, 2024)

Form of Non-Employee Director Restricted Stock Unit Award (Time-Vesting) Award Certificate (rev. 2024) under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 24, 2024)

Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on May 31, 2024)

Separation Agreement, dated as of November 13, 2023, by and between Alkermes plc and Mural Oncology plc (Filed With SEC on November 15, 2023)

Tax Matters Agreement, dated as of November 13, 2023, by and between Alkermes plc and Mural Oncology plc (Filed With SEC on November 15, 2023)

Employee Matters Agreement, dated as of November 13, 2023, by and between Alkermes plc and Mural Oncology plc (Filed With SEC on November 15, 2023)

Transition Services Agreement, dated as of November 13, 2023, by and between Alkermes, Inc. and Mural Oncology, Inc (Filed With SEC on November 15, 2023)

Transition Services Agreement, dated as of November 13, 2023, by and between Mural Oncology, Inc. and Alkermes, Inc (Filed With SEC on November 15, 2023)

Confidential Settlement and License Agreement, dated August 29, 2023, by and among Alkermes, Inc., Alkermes Pharma Ireland Limited and Teva Pharmaceuticals USA, Inc (Filed With SEC on October 25, 2023)

Supply Agreement, dated September 26, 2003, by and between Acorda Therapeutics, Inc. and Elan Corporation, plc (Filed With SEC on October 25, 2023)

Development and Supplemental Agreement between Elan Pharma International Limited and Acorda Therapeutics, Inc. dated January 14, 2011 (Filed With SEC on October 25, 2023)

License Agreement by and among Elan Pharmaceutical Research Corp., d/b/a Nanosystems and Elan Pharma International Limited and Janssen Pharmaceutica N.V. dated as of March 31, 1999 (Filed With SEC on April 26, 2023)

Agreement Amendment No. 2, dated as of July 31, 2009, to the License Agreement by and among Elan Pharmaceutical Research Corp., d/b/a Nanosystems and Elan Pharma International... (Filed With SEC on April 26, 2023)

Description of Securities (Filed With SEC on February 16, 2023)

Form of Incentive Stock Option Award Certificate for Reporting Officers under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on February 16, 2023)

Form of Non-Qualified Stock Option Award Certificate for Reporting Officers under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on February 16, 2023)

Form of Restricted Stock Unit (Time-Vesting) Award Certificate for Reporting Officers under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on February 16, 2023)

Form of Restricted Stock Unit (Performance-Vesting) Award Certificate for Reporting Officers under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on February 16, 2023)

Fourth Amendment to License and Collaboration Agreement between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH, effective as of August 25, 2022 (Filed With SEC on November 2, 2022)

Form of Non-Employee Director New Director Grant Non-Qualified Stock Option Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 27, 2022)

Form of Non-Employee Director New Director Grant Restricted Stock Unit (Time-Vesting) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 27, 2022)

Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 7, 2022)

Description of Securities (Filed With SEC on February 16, 2022)

ALKERMESplc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on February 16, 2022)

Summary of agreement reached on April 29, 2021 between Alkermes plc and Sarissa Capital Offshore Master Fund LP (Filed With SEC on July 28, 2021)

Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on June 14, 2021)

Description of Securities (Filed With SEC on February 11, 2021)

Cooperation Agreement, dated December 10, 2020, by and among Alkermes plc, Elliott Investment Management L.P., Elliott Associates, L.P., Elliott Advisors (UK) Limited and Elliott... (Filed With SEC on December 10, 2020)

Third Amendment to Purchase and Sale Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Daravita Limited, Alkermes US Holdings, Inc. (as successor in... (Filed With SEC on October 29, 2020)

Sixth Amendment to Lease between Alkermes, Inc. and GI TC 850 Winter Street, LLC, dated as of July 24, 2020 (Filed With SEC on October 29, 2020)

Offer Letter between Alkermes, Inc. and Christian Todd Nichols, dated March 29, 2019 (Filed With SEC on July 29, 2020)

Form of Non-Qualified Stock Option (Non-Employee Director) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 29, 2020)

Form of Restricted Stock Unit (Time-Vesting) (Non-Employee Director) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 29, 2020)

Form of Restricted Stock Unit Award Certificate (Performance-Vesting) under the Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on July 29, 2020)

Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on May 20, 2020)

Form of Deed of Indemnification entered into by and between Alkermes plc and the directors and Secretary of Alkermes plc (Filed With SEC on April 29, 2020)

Form of Indemnification Agreement entered into by and between Alkermes, Inc. and the executive officers and directors of Alkermes plc (Filed With SEC on April 29, 2020)

Description of Securities (Filed With SEC on February 13, 2020)

In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by [**]) has been excluded from this exhibit because it is both not material and would... (Filed With SEC on February 13, 2020)

Agreement and Plan of Merger, dated as of November 14, 2019, by and among Alkermes plc, Alkermes, Inc., Thinker Merger Sub, Inc., Rodin Therapeutics, Inc., and Shareholder... (Filed With SEC on November 25, 2019)

Second Amendment to Lease, dated May 10, 2019, by and between Alkermes, Inc. and PDM 900 Unit, LLC (Filed With SEC on July 25, 2019)

Alkermes plc 2018 Stock Option and Incentive Plan, as amended (Filed With SEC on May 22, 2019)

Second Amendment, effective as of January 31, 2019, to License and Collaboration Agreement by and between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH dated... (Filed With SEC on April 25, 2019)

Second Amendment to Purchase and Sale Agreement, dated December 20, 2018, by and among Alkermes Pharma Ireland Limited, Daravita Limited, Alkermes US Holdings, Inc. (as successor... (Filed With SEC on February 15, 2019)

Fifth Amendment to Lease between Alkermes, Inc. and GI TC 850 Winter Street, LLC, dated as of October 31, 2018 (Filed With SEC on February 15, 2019)

Form of Incentive Stock Option Award Certificate under the Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on October 23, 2018)

Form of Non-Qualified Stock Option (Employee) Award Certificate under the Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on October 23, 2018)

Form of Restricted Stock Unit (Time-Vesting) Award Certificate under the Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on October 23, 2018)

Form of Restricted Stock Unit (Performance-Vesting) Award Certificate under the Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on October 23, 2018)

Form of Non-Qualified Stock Option (Non-Employee Director) Award Certificate under the Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on October 23, 2018)

Form of Incentive Stock Option Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan (Filed With SEC on October 23, 2018)

Form of Non-Qualified Stock Option (Employee) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan (Filed With SEC on October 23, 2018)

Form of Restricted Stock Unit (Time-Vesting) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan (Filed With SEC on October 23, 2018)

Form of Restricted Stock Unit (Performance-Vesting) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan (Filed With SEC on October 23, 2018)

Form of Non-Qualified Stock Option (Non-Employee Director) Award Certificate under the Alkermes plc 2018 Stock Option and Incentive Plan (Filed With SEC on October 23, 2018)

Sixth Amendment to the Manufacturing and Supply Agreement by and between JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II... (Filed With SEC on October 23, 2018)

First Amendment to License and Collaboration Agreement between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH, effective as of October 3, 2018 (Filed With SEC on October 23, 2018)

First Amendment to Lease, dated June 21, 2018, by and between Alkermes, Inc. and PDM 900 Unit, LLC (Filed With SEC on July 26, 2018)

Alkermes plc 2018 Stock Option and Incentive Plan (Filed With SEC on May 23, 2018)

Offer Letter between Alkermes, Inc. and James R. Robinson, Jr., dated February 28, 2018 (Filed With SEC on April 26, 2018)

Third Amendment to Development and License Agreement, dated March 20, 2018, by and between Amylin Pharmaceuticals, LLC and Alkermes Pharma Ireland Limited (as... (Filed With SEC on April 26, 2018)

Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on May 24, 2017)

Alkermes plc Amended and Restated 2008 Stock Option and Incentive Plan, as amended (Filed With SEC on April 27, 2017)

Alkermes plc 2011 Stock Option and Incentive Plan, as amended (Filed With SEC on April 27, 2017)

FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on February 17, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on November 2, 2016)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on May 26, 2016)

ALKERMES plc Amended and Restated 2008 Stock Option and Incentive Plan (Filed With SEC on April 28, 2016)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on April 28, 2016)

SEPARATION AGREEMENT (Filed With SEC on February 25, 2016)

LICENSE AGREEMENT (Filed With SEC on February 25, 2016)

MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on February 25, 2016)

ADDENDUM TO MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on February 25, 2016)

Alkermes Controlled Therapeutics Inc. II 64 Sidney Street Cambridge, MA 02139 USA (Filed With SEC on February 25, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)

LICENSE AGREEMENT (Filed With SEC on July 30, 2015)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH "*" AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on July 30, 2015)

AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on July 30, 2015)

FOURTH AMENDMENT TO LEASE (Filed With SEC on July 30, 2015)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)

ALKERMES plc Amended and Restated 2008 Stock Option and Incentive Plan (Filed With SEC on April 30, 2015)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on April 30, 2015)

Alkermes plc Affiliated Company Fiscal Year 2015 Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on December 5, 2014)

AMENDMENT NO. 3 AND WAIVER TO AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on October 29, 2014)

Third Amendment to Lease (Filed With SEC on July 31, 2014)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on May 28, 2014)

ALKERMES PUBLIC LIMITED COMPANY 5,917,160 Ordinary Shares Pricing Term Sheet (Filed With SEC on January 13, 2014)

Alkermes plc Affiliated Company Fiscal Year 2014 Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on December 9, 2013)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on August 1, 2013)

ELAN PHARMA INTERNATIONAL LIMITED AND ACORDA THERAPEUTICS, INC. DEVELOPMENT AND SUPPLEMENTAL AGREEMENT TO AMENDED AND RESTATED LICENSE AGREEMENT DATED 26 SEPTEMBER 2003 AS AMENDED... (Filed With SEC on May 23, 2013)

Date: 26, September 2003 ELAN CORPORATION, PLC. AND ACORDA THERAPEUTICS, INC. SUPPLY AGREEMENT (Filed With SEC on May 23, 2013)

LICENSE AGREEMENT by and among ELAN PHARMACEUTICAL RESEARCH CORP., d/b/a NANOSYSTEMS and ELAN PHARMA INTERNATIONAL LIMITED and JANSSEN PHARMACEUTICA N.V. March 31, 1999 This... (Filed With SEC on May 23, 2013)

Agreement Amendment No. 2 (Filed With SEC on May 23, 2013)

AMENDMENT NO. 3 AND WAIVER TO AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on May 23, 2013)

Vesting Date (Filed With SEC on May 23, 2013)

Vest Date (Filed With SEC on May 23, 2013)

Amended and Restated Fiscal Year December 2013 Alkermes plc Affiliated Company Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on May 23, 2013)

Fiscal 2014 Alkermes plc Affiliated Company Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on April 1, 2013)

AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on February 19, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on November 1, 2012)

Fiscal 2013 Alkermes plc Affiliated Company Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on November 1, 2012)

SECOND AMENDMENT TO LICENSE AGREEMENTS FIFTH AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 1, 2012)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on August 6, 2012)

Fiscal 2013 Alkermes plc Affiliated Company Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on March 30, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2012)

ALKERMES, INC LETTERHEAD (Filed With SEC on March 5, 2012)

Alkermes plc Ordinary Shares ($0.01 par value) Form of Underwriting Agreement (Filed With SEC on February 29, 2012)

Certificate Number (Filed With SEC on February 29, 2012)

ALKERMES plc 2011 Stock Option and Incentive Plan (Filed With SEC on December 8, 2011)

ALKERMES PLC (Filed With SEC on September 20, 2011)

ALKERMES, INC. (Filed With SEC on September 20, 2011)

Fiscal 2012 Alkermes plc Affiliated Company Reporting Officer Performance Pay Plan (the Plan) (Filed With SEC on September 20, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on September 20, 2011)

Category

Industry

Companies

Contracts

Alkermes plc. Contracts & Agreements